Transversal phaco, venturi pump yield nuclear fragment control

Article

ECC slightly better 6 months postopcompared with longitudinal phaco and peristaltic pump

Cataract removal using transversal phaco (Whitestar Signature with Ellips Transversal Ultrasound, Abbott Medical Optics) with a Venturi pump improved the followability of nuclear fragments and reduced chatter at the phaco tip compared with conventional longitudinal phaco with a peristaltic pump. Six months postoperatively, the endothelial cell count (ECC) was only slightly decreased with transversal phaco compared with longitudinal phaco.

Developments in phacoemulsification continue to evolve, according to Dr Matteo Piovella. He described the latest generation of torsional and transversal phacoemulsification and compared their effects during the annual meeting of the American Society of Cataract and Refractive Surgery.

As the technology advances, he added, the ultimate goals of phaco are shorter surgeries, fewer problems, and greater effectiveness.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.